The company
Axogen, Inc.
AXGN · Nasdaq
AXGN stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 16.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $25.8M
- Officials’ trades on record
- 2
- Institutions holding
- 239 (+32)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
2 disclosed lines: House 2, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 24 Jun 2019filed 27 Apr 2020 |
| Donna E. Shalala House: U.S. House ClerkFL27 | bought | $1k–$15k | 16 Apr 2019filed 27 Apr 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Joseph A. TyndallDirector | sold | 3,500at $49.70 | 2 Sep 2026filed 4 Sep 2026 |
| Amy McBride WendellDirector | sold | 13,353at $48.42 | 11 Aug 2026filed 12 Aug 2026 |
| Marc A. BeganEVP & General Counsel | sold | 67,500at $47.35 | 10 Aug 2026filed 12 Aug 2026 |
| Kathy Johnson WeilerDirector | sold | 14,150at $45.30 | 7 Aug 2026filed 11 Aug 2026 |
| Amy McBride WendellDirector | sold | 1,647at $42.60 | 8 May 2026filed 12 May 2026 |
| Doris QuackenbushSales VP | sold | 3,878at $43.51 | 7 May 2026filed 8 May 2026 |
| Lindsey Marie HartleyCFO | sold | 478at $43.67 | 7 May 2026filed 8 May 2026 |
| Lindsey Marie HartleyCFO | sold | 573at $43.67 | 7 May 2026filed 8 May 2026 |
| Jens KempChief Marketing Officer | sold | 4,000at $43.44 | 7 May 2026filed 8 May 2026 |
| Kathy Johnson WeilerDirector | sold | 16,344at $44.09 | 7 May 2026filed 8 May 2026 |
| John JohnsonDirector | sold | 11,050at $43.26 | 7 May 2026filed 8 May 2026 |
| Erick Wayne DevinneyChief Innovation Officer | sold | 5,221at $32.84 | 16 Mar 2026filed 18 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,419,208$204.1M | +548,357+14.2% |
| First Light Asset Management, LLCreduced · filed 14 Aug 2026 | 2,748,361$126.9M | -1,254,407−31.3% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 2,747,924$126.9M | -375,058−12.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,257,948$104.3M | -33,615−1.5% |
| Polar Capital Holdings Plcunchanged · filed 14 Aug 2026 | 1,500,822$69.3M | 00.0% |
| Artemis Investment Management LLPadded · filed 23 Jul 2026 | 1,396,792$64.5M | +1,046,904+299.2% |
| WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026 | 1,391,654$64.3M | +427,089+44.3% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,375,240$63.5M | +155,099+12.7% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 1,360,831$62.9M | +1,115,777+455.3% |
| WASATCH ADVISORS LPreduced · filed 10 Jul 2026 | 1,295,949$59.9M | -561,401−30.2% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.